Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_assertion type Assertion NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_head.
- NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_assertion description "[MST was respectively of 109 and 196 weeks for patients with or without EGFR overexpression and patients with EGFR gene abnormalities had also a shorter survival with MST 136 weeks versus 189 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_provenance.
- NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_assertion evidence source_evidence_literature NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_provenance.
- NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_assertion SIO_000772 15713516 NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_provenance.
- NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_assertion wasDerivedFrom befree-20140225 NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_provenance.
- NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_assertion wasGeneratedBy ECO_0000203 NP913926.RACBRpUllrxbHtW4CFVHNv_luGqrlC1V0Py-PanoAzIRU130_provenance.